Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP)-Reference-Cited by-同舟云学术

Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP)

Published:2018-04 Issue: Volume:109 Page:153-157
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Lindborg Carter M.,Brennan Tracy A.,Wang Haitao,Kaplan Frederick S.,Pignolo Robert J.

Funder

Clementia Pharmaceuticals, Inc.

University of Pennsylvania

Ian Cali Distinguished Clinician-Scientist award

Mayo Clinic

Radiant Hope Foundation

Ian Cali Endowment for FOP Research

Whitney Weldon Endowment for FOP Research

Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine

Penn

National Institutes of Health

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Nonhereditary heterotopic ossification: implications for injury, arthropathy, and aging;Pignolo;Clin. Rev. Bone Miner. Metab.,2005

2. Heterotopic ossification: basic-science principles and clinical correlates;Ranganathan;J. Bone Joint Surg. Am.,2015

3. Fibrodysplasia ossificans progressiva: clinical and genetic aspects;Pignolo;Orphanet J. Rare Dis.,2011

4. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons;Pignolo;Pediatr. Endocrinol. Rev.,2013

5. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva;Shore;Nat. Genet.,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrodysplasia ossificans progressiva (clinical observation with a brief review of the literature);N.N. Priorov Journal of Traumatology and Orthopedics;2024-07-04

2. Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva;Biomedicines;2024-04-02

3. Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva;BMC Medical Research Methodology;2023-11-13

4. The role of miRNA and lncRNA in heterotopic ossification pathogenesis;Stem Cell Research & Therapy;2022-12-15

5. Diminished muscle integrity in patients with fibrodysplasia ossificans progressiva assessed with at-home electrical impedance myography;Scientific Reports;2022-12-03